Estimaciones de analistas de Wall Street para Cytokinetics, Incorporated (CYTK): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | -52.77 |
| EV / EBITDA | -11.34 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $106.4M | $13.4M | $31.5M | $26.9M | $55.8M | $70.4M | $94.6M | $7.5M | $18.5M | $88.0M |
| Coste de Ventas | $64.4M | $90.3M | $89.1M | $86.1M | $97.0M | $159.9M | $240.8M | $330.1M | $339.4M | $10.1M |
| Beneficio Bruto | $42.0M | -$76.9M | -$57.6M | -$59.3M | -$41.1M | -$89.5M | -$146.2M | -$322.6M | -$320.9M | $77.9M |
| I+D | $59.9M | $90.3M | $89.1M | $86.1M | $97.0M | $159.9M | $240.8M | $330.1M | $339.4M | $405.9M |
| Generales y Administrativos | $27.8M | $36.5M | $31.3M | $39.6M | $52.8M | $96.8M | $178.0M | $173.6M | $215.3M | $284.3M |
| Gastos Operativos | $23.3M | $36.5M | $31.3M | $39.6M | $52.8M | $96.8M | $178.0M | $173.6M | $215.3M | $690.2M |
| Beneficio Operativo | $18.7M | -$113.4M | -$88.9M | -$98.9M | -$93.9M | -$186.3M | -$324.2M | -$496.2M | -$536.2M | -$612.3M |
| EBITDA | $14.9M | -$108.9M | -$83.5M | -$93.0M | -$86.8M | -$176.3M | -$329.4M | -$456.7M | -$493.5M | -$775.3M |
| Gastos por Intereses | $2.2M | $17.0M | $21.6M | $27.4M | $38.7M | $29.3M | $51.2M | $57.7M | $86.5M | $103.9M |
| Beneficio Antes de Impuestos | $16.5M | -$127.8M | -$106.3M | -$121.7M | -$127.3M | -$215.3M | -$389.0M | -$526.2M | -$589.5M | -$785.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $16.5M | -$127.8M | -$106.3M | -$121.7M | -$127.3M | -$215.3M | -$389.0M | -$526.2M | -$589.5M | -$785.0M |
| BPA | $0.41 | $-2.59 | $-1.95 | $-2.59 | $-1.97 | $-2.80 | $-4.33 | $-5.45 | $-5.26 | $-6.54 |
| BPA Diluido | $0.39 | $-2.59 | $-1.95 | $-2.59 | $-1.97 | $-2.80 | $-4.33 | $-5.45 | $-5.26 | $-6.54 |
| Acciones en Circulación (Diluidas) | $42.6M | $49.4M | $54.4M | $57.6M | $64.5M | $76.9M | $89.8M | $96.5M | $112.0M | $120.1M |
Precio
| Precio | $73.45 |
| Capitalización | $9.1B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABVX · AXSM · CORT · CRSP · HALO · JAZZ · MRUS
Explorar sector: Healthcare · Biotechnology
Más secciones de CYTK: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones